Neoadjuvant therapy

Top PDF Neoadjuvant therapy:

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades

... of neoadjuvant therapy for patients without evidence of metastatic ...The neoadjuvant approach, gives the chance of receive CT treatment in most of medically fit ...

13

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

... adjuvant therapy provides a significant survival benefit in esophageal SCC when compared to surgery ...2 neoadjuvant treatment strategies is ...following neoadjuvant therapy is not yet ...

8

Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence

Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence

... Our study detected that four out of five relapsed breast cancer patients carried the KMT2C c.5053G>T mutation. Kaplan-Meier survival and multivariate analyses found that KMT2C, like other clinical factors, was ...

12

Short Term Effect of Neoadjuvant Therapy with  Docetaxel and Adriamycin in Advanced Breast  Cancer

Short Term Effect of Neoadjuvant Therapy with Docetaxel and Adriamycin in Advanced Breast Cancer

... Clinical course of breast cancer patients with pathologic primary tumor and axillary lyph node response to doxorubicin-based neoadjuvant chemo- therapy.. Prospective e[r] ...

7

Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient

Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient

... The benefit of NAT, which is the focus of this article, lies in the opportunity to offer SLNB instead of ALND in patients with node positive breast cancer that was cleared by NAT. This consequently saves patients from ...

4

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors

... total neoadjuvant therapy, wherein the treatment which is usually administered as postoperative (adjuvant) chemo- therapy is shifted to the preoperative ...

5

JKSSJKSSJKSSJournal of the Korean Surgical Society pISSN 2233-7903ㆍ

Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer

... after neoadjuvant therapy with trastu- zumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor re- ceptor 2-positive operable breast ...

8

Neoadjuvant Hormonal Therapy Preceding Radical Prostatectomy for Clinically Localized Prostate Cancer: Early Postoperative Complications and Biochemical Recurrence

Neoadjuvant Hormonal Therapy Preceding Radical Prostatectomy for Clinically Localized Prostate Cancer: Early Postoperative Complications and Biochemical Recurrence

... Words: Neoadjuvant therapy; Prostatectomy; Prostatic neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ...

5

Neoadjuvant Treatment for Gastric Cancer

Neoadjuvant Treatment for Gastric Cancer

... vestigating neoadjuvant therapy in locally advanced gastric ...cancer therapy can be observed in Asia and Europe: while Asian countries rely on surgery followed by adjuvant chemotherapy perioperative ...

6

The Efficacy of Hepatic Resection after Neoadjuvant TransarterialChemoembolization (TACE) and Radiation Therapy in HepatocellularCarcinoma Greater Than 5 cm in Size

The Efficacy of Hepatic Resection after Neoadjuvant TransarterialChemoembolization (TACE) and Radiation Therapy in HepatocellularCarcinoma Greater Than 5 cm in Size

... mination of radiation therapy and hepatic resection was 4.7 months. The median tumor diameter before the neoadjuvant therapy measured on the CT scans was 10.0 cm (with a range of 6.3-18.0 cm). ...

6

Evaluation of Neoadjuvant Chemotherapy Effect in Osteosarcoma

Evaluation of Neoadjuvant Chemotherapy Effect in Osteosarcoma

... assess neoadjuvant chemotherapy effect for osteosarcoma, reduction rate of SUVmax was a useful indicator in this ...osteosarcoma, neoadjuvant therapy, necrosis, positron-emission ...

8

Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer

Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer

... Background: We evaluated the feasibility and outcomes of pulmonary resection and mediastinal node dis- section (MND) by video-assisted thoracoscopic surgery (VATS) following neoadjuvant therapy for stage ...

6

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype

... 15. Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008;26:1275-81. ...

13

Evaluation of the effect of neoadjuvant treatment in pancreatic ductal adenocarcinoma

Evaluation of the effect of neoadjuvant treatment in pancreatic ductal adenocarcinoma

... the Neoadjuvant Therapy Working Group of the Pancreatobiliary Pathology Society are currently work- ing to provide pathologists all over the world with an easy, highly reproducible, standardized and ...

1

Efficacy of Adjuvant Chemotherapy after Neoadjuvant FOLFIRINOX and Following Resection  of Pancreatic Cancer

Efficacy of Adjuvant Chemotherapy after Neoadjuvant FOLFIRINOX and Following Resection of Pancreatic Cancer

... 요약: 췌장암의 첫 진단 시 수술이 가능한 경우는 약 20% 에 불과하며, 절제를 시행한 경우 수술 후 항암제 보조요법 (adjuvant chemotherapy)으로 생존 기간 증가 및 암 재발 감소 효과를 기대할 수 있다. 1,2 그러나 표준 치료인 수술 및 수술 후 보조요법에도 불구하고, 약 75%의 환자에서 2년 내 에 암이 재발한다. 3 이러한 사실 때문에 최근 비전이성 췌장암 도 ...

2

Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor

Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor

... Adjuvant therapy with imatinib was recently approved for use, and preoperative imatinib is an emerging treatment option for patients who require cytoreductive ...IM neoadjuvant therapy for primary ...

6

JKSSJKSSJKSSJournal of the Korean Surgical Society pISSN 2233-7903ㆍ

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer

... Department of Surgery, Yonsei University College of Medicine, Seoul, 1 Department of Surgery, Hansol Hospital, Seoul, Korea Purpose: The optimal time between neoadjuvant chemoradiotherapy (CRT) and surgery for ...

8

Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks

Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks

... 1 Division of Interventional Radiology, New York Presbyterian Hospital – Weill Cornell Medical Center, 2 Department of Cardiovasular Sciences, East Carolina University, 3 Department of Surgery, University of Iowa ...

8

Lymph Node Status after Neoadjuvant Chemoradiation Therapy for Esophageal Cancer according to Radiation Field Coverage

Lymph Node Status after Neoadjuvant Chemoradiation Therapy for Esophageal Cancer according to Radiation Field Coverage

... We sought to identify risk factors for pathological involvement in rLNs. In logistic regression analysis, ypT0 stage and R0 resection were positive predictors of pathological negativity. It is known that pCR re- duces ...

7

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement

... However, in the clinical setting of postoperative adjuvant treatment, problems often arose with ensuring appropriate timing for systemic treatment due to delayed postoperative recovery or medical comorbidity. 11,14,15 ...

9

Show all 3571 documents...

Related subjects